Allogene Therapeutics Inc (ALLO) President and CEO David D Chang Bought $720,000 of Shares

President and CEO of Allogene Therapeutics Inc (ALLO, Financial) David D Chang bought 40,000 shares of ALLO on 10/15/2018 at an average price of $18 a share. The total cost of this purchase was $720,000.

Allogene Therapeutics Inc has a market cap of $2.88 billion; its shares were traded at around $24.98 .

CEO Recent Trades:

  • President and CEO David D Chang bought 40,000 shares of ALLO stock on 10/15/2018 at the average price of $18. The price of the stock has increased by 38.78% since.

Directors and Officers Recent Trades:

  • Director Owen N. Witte bought 15,000 shares of ALLO stock on 10/15/2018 at the average price of $18. The price of the stock has increased by 38.78% since.
  • Director Franz B Humer bought 30,000 shares of ALLO stock on 10/15/2018 at the average price of $18. The price of the stock has increased by 38.78% since.
  • Director, 10% Owner Arie Belldegrun bought 35,000 shares of ALLO stock on 10/15/2018 at the average price of $18. The price of the stock has increased by 38.78% since.
  • 10% Owner Inc Pfizer bought 55,556 shares of ALLO stock on 10/15/2018 at the average price of $18. The price of the stock has increased by 38.78% since.
  • 10% Owner Group Holdings (sbs) Advis Tpg bought 675,000 shares of ALLO stock on 10/15/2018 at the average price of $18. The price of the stock has increased by 38.78% since.

For the complete insider trading history of ALLO, click here

.